FDA authorizes initial generic single-dose flu medication

The U.S. Food and Drug Administration has approved the first generic version of baloxavir marboxil, a single-dose influenza treatment. This decision aims to improve patient access to flu medication ahead of the upcoming flu season. The approval covers treatment and prevention for individuals aged five and older.